Digital Metabolic Rehab for COPD

Recruiting in Palo Alto (17 mi)

Overseen byDoug Klein, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Alberta

No Placebo Group

Trial Summary

What is the purpose of this trial?

People with Chronic Obstructive Pulmonary Disease (COPD) are at greater risk for Metabolic syndrome (MetS). Although the management of MetS will not cure COPD, it can beneficially impact health outcomes and quality of life through lifestyle modifications. The study aims to determine if using the Digital Metabolic Rehab program, which is based on preventive self-care and includes three key pillars of health: nutrition, fitness, and mindfulness, will be feasible to reduce or reverse MetS for individuals living with COPD.

Research Team

Doug Klein, MD

Principal Investigator

University of Alberta

Liam Collins, MS

Principal Investigator

University of Alberta

Eligibility Criteria

This trial is for adults over 18 with COPD stages 1 or 2 and an adjusted BMI of 26-40, who have at least two MetS factors identified by their doctor. Participants must speak English and be willing to use technology for self-care. It's not suitable for those with severe medical conditions, uncontrolled metabolic disorders, advanced heart failure, stroke history, substance abuse issues, active cancer treatment or certain diabetes complications.

Inclusion Criteria

I have mild or moderate COPD.

I am 18 years old or older.

Your BMI is between 26 and 40 after adjustments are made.

See 2 more

Exclusion Criteria

My kidney function is normal, not failing.

I do not have severe health issues like advanced COPD, heart failure, or uncontrolled diabetes.

I have diabetes with serious complications like eye, kidney issues, nerve problems, very high blood sugar, or leg pain.

See 4 more

Treatment Details

Interventions

Digital Metabolic Rehab (Behavioral Intervention)

Trial OverviewThe Digital Metabolic Rehab program is being tested to see if it can help people with COPD reduce or reverse Metabolic Syndrome through nutrition, fitness, and mindfulness. The study will assess the feasibility of this preventive self-care based program in improving health outcomes.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Single-arm pilot trialExperimental Treatment1 Intervention

The Digital Metabolic Rehabilitation is a single-arm pilot trial that assesses Canadian Digital Technology's feasibility in preventing and managing MetS in patients living with COPD for a 6-month program.